Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)
This grant funds research on novel mechanisms related to neuropsychiatric symptoms in Alzheimer's dementia.
About this program
The Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia grant supports innovative research aimed at understanding the underlying mechanisms of neuropsychiatric symptoms associated with Alzheimer's disease. This research is crucial for developing effective interventions and improving the quality of life for patients suffering from these symptoms. The grant is open to researchers and institutions engaged in clinical trials or exploratory studies that can contribute to this field of study. Eligible applicants include academic institutions, nonprofit organizations, and other entities involved in health-related research. The grant encourages interdisciplinary approaches and collaboration among researchers to foster innovative solutions. By focusing on neuropsychiatric symptoms, this grant aims to bridge the gap between basic research and clinical application, ultimately benefiting patients and caregivers dealing with Alzheimer's dementia.
Eligibility
Academic institutions, nonprofit organizations, and other entities involved in health-related research.